Literature DB >> 30690207

Osteocytes respond to particles of clinically-relevant conventional and cross-linked polyethylene and metal alloys by up-regulation of resorptive and inflammatory pathways.

Renee T Ormsby1, Lucian B Solomon2, Dongqing Yang1, Tania N Crotti3, David R Haynes3, David M Findlay1, Gerald J Atkins4.   

Abstract

Periprosthetic osteolysis is a major cause of implant failure in total hip replacements. Aseptic loosening caused by osteolytic lesions is associated with the production of bioactive wear particles from the articulations of implants. Wear particles infiltrate the surrounding tissue of implants, promoting inflammation as well as bone resorption. Osteocytes have been shown to both regulate physiological osteoclastogenesis and directly remodel their perilacunar bone matrix by the process of osteocytic osteolysis. We hypothesise that osteocytes respond to wear debris of orthopaedic implant materials by adopting a pro-catabolic phenotype and thus contribute to periprosthetic osteolysis through the known pathways of bone loss. Osteocyte responses to particles derived from clinically relevant materials, ultra-high molecular weight polyethylene (UHMWPE), highly cross-linked polyethylene (XLPE) and metal alloys, Ti6Al4V and CoCrMo, were examined in vitro in human primary osteocyte-like cultures. Osteocyte-like cells exposed to both polyethylene and metal wear particle types showed upregulated expression of catabolic markers associated with osteocytic osteolysis, MMP13, carbonic anhydrase 2 (CA2) and cathepsin K (CTSK). In addition, pro-osteoclastogenesis markers RANKL and M-CSF were induced, as well as the expression of pro-inflammatory cytokines, IL-6 and TNFα, albeit with different kinetics. These findings suggest a previously unrecognised action of wear particles of multiple orthopaedic materials on osteocytes, and suggest a multifaceted role for osteocytes in periprosthetic osteolysis. STATEMENT OF SIGNIFICANCE: This study addresses periprosthetic osteolysis, a major clinical problem leading to aseptic loosening of orthopaedic implants. It is well accepted that wear particles of polyethylene and of other implant materials stimulate the activity of bone resorbing osteoclasts. Our recent work provided evidence that commercial particles of ultra-high molecular weight polyethylene (UHMWPE) stimulated osteocytes to adopt a bone catabolic state. In this study we demonstrate for the first time that particles derived from materials in clinical use, conventional UHMWPE, highly cross-linked polyethylene (XLPE), and Ti6Al4V and CoCrMo metal alloys, all stimulate human osteocyte activities of osteocyte-regulated osteoclastogenesis, osteocytic osteolysis, proinflammatory responses, osteocyte apoptosis, albeit to varying extents. This study provides further mechanistic insight into orthopaedic wear particle mediated bone disease in terms of the osteocyte, the most abundant and key controlling cell type in bone.
Copyright © 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cobalt chrome; Osteocyte; Polyethylene; Titanium alloy; Wear particle

Mesh:

Substances:

Year:  2019        PMID: 30690207     DOI: 10.1016/j.actbio.2019.01.047

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  15 in total

1.  Hindlimb unloading causes regional loading-dependent changes in osteocyte inflammatory cytokines that are modulated by exogenous irisin treatment.

Authors:  Corinne E Metzger; S Anand Narayanan; Peter H Phan; Susan A Bloomfield
Journal:  NPJ Microgravity       Date:  2020-10-07       Impact factor: 4.415

Review 2.  Diagnosis and management of implant debris-associated inflammation.

Authors:  Stuart B Goodman; Jiri Gallo; Emmanuel Gibon; Michiaki Takagi
Journal:  Expert Rev Med Devices       Date:  2019-12-17       Impact factor: 3.166

3.  Quantitative Measurements of Backside Wear in Acetabular Hip Joint Replacement: Conventional Polyethylene Versus Cross-Linked Polyethylene.

Authors:  Steffen Braun; Sebastian Jaeger; Robert Sonntag; Stefan Schroeder; J Philippe Kretzer
Journal:  Materials (Basel)       Date:  2020-04-15       Impact factor: 3.623

4.  Reduction of SOST gene promotes bone formation through the Wnt/β-catenin signalling pathway and compensates particle-induced osteolysis.

Authors:  Zai Hang Zhang; Xin Yu Jia; Jing Yi Fang; Hao Chai; Qun Huang; Chang She; Peng Jia; De Chun Geng; Wei Xu
Journal:  J Cell Mol Med       Date:  2020-03-05       Impact factor: 5.310

Review 5.  Mechanisms of Adverse Local Tissue Reactions to Hip Implants.

Authors:  Felipe Eltit; Qiong Wang; Rizhi Wang
Journal:  Front Bioeng Biotechnol       Date:  2019-07-30

6.  Tussilagone Inhibits Osteoclastogenesis and Periprosthetic Osteolysis by Suppressing the NF-κB and P38 MAPK Signaling Pathways.

Authors:  Xuantao Hu; Ziqing Yin; Xia Chen; Guangyao Jiang; Daishui Yang; Ziqin Cao; Shuai Li; Zicheng Liu; Dan Peng; Pengcheng Dou
Journal:  Front Pharmacol       Date:  2020-04-03       Impact factor: 5.810

7.  Evidence for Gender-Specific Bone Loss Mechanisms in Periprosthetic Osteolysis.

Authors:  Renee T Ormsby; Lucian B Solomon; Roumen Stamenkov; David M Findlay; Gerald J Atkins
Journal:  J Clin Med       Date:  2019-12-24       Impact factor: 4.241

Review 8.  Periprosthetic Osteolysis: Mechanisms, Prevention and Treatment.

Authors:  Stuart B Goodman; Jiri Gallo
Journal:  J Clin Med       Date:  2019-12-01       Impact factor: 4.241

9.  Relationships between the Bone Expression of Alzheimer's Disease-Related Genes, Bone Remodelling Genes and Cortical Bone Structure in Neck of Femur Fracture.

Authors:  Catherine J M Stapledon; Roumen Stamenkov; Roberto Cappai; Jillian M Clark; Alice Bourke; L Bogdan Solomon; Gerald J Atkins
Journal:  Calcif Tissue Int       Date:  2021-01-04       Impact factor: 4.333

10.  Puerarin inhibits titanium particle-induced osteolysis and RANKL-induced osteoclastogenesis via suppression of the NF-κB signaling pathway.

Authors:  Wenkai Tang; Long Xiao; Gaoran Ge; Mengdan Zhong; Jie Zhu; Jialin Qin; Chencheng Feng; Wenhao Zhang; Jiaxiang Bai; Xuesong Zhu; Minggang Wei; Dechun Geng; Zhirong Wang
Journal:  J Cell Mol Med       Date:  2020-09-07       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.